sábado, 20 de setembro de 2008

Doctor's Guide, Setembro, 12


FDA: TNF Blockers Increase Risk of Invasive Fungal Infections, Delayed Treatment Can Result in Death
ROCKVILLE, Md -- September 4, 2008 -- The US Food and Drug Administration (FDA) is notifying healthcare professionals that histoplasmosis and other invasive fungal infections are not consistently recognised in patients taking tumor necrosis factor-alpha blockers (TNF blockers), certolizumab pegol (Cimzia), etanercept (Enbrel), adalimumab ...Full Story





Most read General Medicine news in the past 7 days

Papers and articles, pertaining to General Medicine, most read by your colleagues in the past 7 days

More news...

In the past 7 days, 221 papers and articles pertaining to General Medicine were added to the DG database. For a full list click here.

Nenhum comentário: